RE: Pet and Human Trials16 Jul 2024 08:31
You’re right Money. Sells have been getting matched in size by bulk buyers. You can see the type of holders in Genflow atm are mainly here for the buy out and the day or 5% gain traders slowly eliminated, as no matter how elastic the share price is, few sell or cry over the price action. Similair companies with patents and officially in the lab conducting FDA trials are being bought out by big pharma for $billions. On the other hand, plenty of pharma are also delisting as they can’t raise funds, but GENF have an enviable cash runway. I’m happy to see the float moving into strong hands and hopefully we see some big news in Q3 as Eric never misses his roadmap targets!